Richard N Boyajian1, Amy Grose2, Nina Grenon2, Kristin Roper2, Karen Sommer2, Michele Walsh2, Anna Snavely2, Susan Neary2, Ann Partridge2, Larissa Nekhlyudov2. 1. Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC rboyajian@partners.org. 2. Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC.
Abstract
INTRODUCTION: Although survivorship care recommendations exist, there is limited evidence about current practices and patient preferences. METHODS: A cross-sectional survey was completed by survivors of lymphoma, head and neck, and gastrointestinal cancers at an academic cancer center. The survey was designed to capture patients' reports of receipt of survivorship care planning and their attitudes, preferences, and perceived needs regarding content and timing of cancer survivorship care information. Elements of survivorship care were based on the Institute of Medicine recommendations, literature review, and clinical experience. RESULTS: Eighty-five survivors completed the survey (response rate, 81%). More than 75% reported receiving a follow-up plan or appointment schedule, a monitoring plan for scans and blood tests, information about short- and long-term adverse effects, and a detailed treatment summary. These elements were reported as desired by more than 90% of responders. Approximately 40% of these elements were only verbally provided. Although more than 70% described not receiving information about employment, smoking cessation, sexual health, genetic counseling, fertility, or financial resources, these elements were not reported as desired. However, "strategies to cope with the fear of recurrence" was most often omitted, yet desired by most respondents. Survivors' preferences regarding optimal timing for information varied depending on the element. CONCLUSIONS: Our study suggests that cancer survivorship care planning is heterogeneous and may not need to be comprehensive, but rather tailored to individual survivors' needs. Providers must assess patient needs early and continue to revisit them during the cancer care continuum.
INTRODUCTION: Although survivorship care recommendations exist, there is limited evidence about current practices and patient preferences. METHODS: A cross-sectional survey was completed by survivors of lymphoma, head and neck, and gastrointestinal cancers at an academic cancer center. The survey was designed to capture patients' reports of receipt of survivorship care planning and their attitudes, preferences, and perceived needs regarding content and timing of cancer survivorship care information. Elements of survivorship care were based on the Institute of Medicine recommendations, literature review, and clinical experience. RESULTS: Eighty-five survivors completed the survey (response rate, 81%). More than 75% reported receiving a follow-up plan or appointment schedule, a monitoring plan for scans and blood tests, information about short- and long-term adverse effects, and a detailed treatment summary. These elements were reported as desired by more than 90% of responders. Approximately 40% of these elements were only verbally provided. Although more than 70% described not receiving information about employment, smoking cessation, sexual health, genetic counseling, fertility, or financial resources, these elements were not reported as desired. However, "strategies to cope with the fear of recurrence" was most often omitted, yet desired by most respondents. Survivors' preferences regarding optimal timing for information varied depending on the element. CONCLUSIONS: Our study suggests that cancer survivorship care planning is heterogeneous and may not need to be comprehensive, but rather tailored to individual survivors' needs. Providers must assess patient needs early and continue to revisit them during the cancer care continuum.
Authors: Kevin C Oeffinger; Melissa M Hudson; Ann C Mertens; Stephanie M Smith; Pauline A Mitby; Debra A Eshelman-Kent; Jennifer S Ford; Judith K Jones; Sharmila Kamani; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2010-12-16 Impact factor: 3.167
Authors: Carrie Tompkins Stricker; Linda A Jacobs; Betsy Risendal; Alison Jones; Sarahlena Panzer; Patricia A Ganz; Karen L Syrjala; Mary S McCabe; K Scott Baker; Kenneth Miller; Jacqueline Casillas; Donald L Rosenstein; Marci Campbell; Steven C Palmer Journal: J Cancer Surviv Date: 2011-10-04 Impact factor: 4.442
Authors: Cherise B Harrington; Jennifer A Hansen; Michal Moskowitz; Briana L Todd; Michael Feuerstein Journal: Int J Psychiatry Med Date: 2010 Impact factor: 1.210
Authors: Patricia A Ganz; Erin E Hahn; Laura Petersen; Michelle E Melisko; John P Pierce; Marlene Von Friederichs-Fitzwater; Karen T Lane; Robert A Hiatt Journal: Clin Breast Cancer Date: 2016-05-14 Impact factor: 3.225
Authors: Carol A Rosenberg; Carol Flanagan; Bruce Brockstein; Jennifer C Obel; Leon H Dragon; Douglas E Merkel; Elaine L Wade; Teresa M Law; Janardan D Khandekar; Thomas A Hensing Journal: J Cancer Surviv Date: 2015-07-16 Impact factor: 4.442
Authors: Ksenya Shliakhtsitsava; Sally A D Romero; Brian W Whitcomb; Jessica R Gorman; Samantha Roberts; H Irene Su Journal: J Adolesc Young Adult Oncol Date: 2017-07-21 Impact factor: 2.223
Authors: Catherine M Alfano; Deborah K Mayer; Smita Bhatia; Jane Maher; Jessica M Scott; Larissa Nekhlyudov; Janette K Merrill; Tara O Henderson Journal: CA Cancer J Clin Date: 2019-03-08 Impact factor: 508.702
Authors: Beeshman S Nandakumar; Joanna E Fardell; Claire E Wakefield; Christina Signorelli; Jordana K McLoone; Jane Skeen; Ann M Maguire; Richard J Cohn Journal: Support Care Cancer Date: 2018-03-02 Impact factor: 3.603
Authors: Jaime M Preussler; Ellen M Denzen; Navneet S Majhail; K Scott Baker; Meggan McCann; Linda J Burns; Jean Yi; Karen L Syrjala Journal: Support Care Cancer Date: 2019-11-15 Impact factor: 3.603
Authors: Janet S de Moor; Kisha Coa; Erin E Kent; Carmen Moten; Sarah Kobrin; Cheryl Altice; K Robin Yabroff Journal: J Cancer Surviv Date: 2018-10-03 Impact factor: 4.442